The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...
Boston-based biotech Avalyn Pharma is the latest to hop on the IPO train, filing to list on the Nasdaq and raise funds for ...
For many life sciences start-ups, bringing on a GC early can be a strategic advantage. An experienced GC can help shape the ...
Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug in the TRPV1 ...
AZ has yet to file for approval of Imfinzi in the frontline setting for earlier-stage HCC, despite its well-established role ...
The FDA has ramped up the pressure on Amgen to withdraw Tavneos for a rare vasculitis condition from the market, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results